According to NIH, at least 15% of people are deficient in this powerhouse vitamin
However, they may not cover your bills if they are used for weight loss
It is built around one thing: fast, low-cost access to compounded GLP-1 medication
Patients: A total of 9650 adult patients with established CV disease without CKD (56.7%), CKD only (13%), or both CV disease and CKD (27%) were randomized 1:1 to receive semaglutide tablets 14 mg (n=4825) or placebo (n=4825) once daily, both in addition to standard-of-care treatments for glycemic control and CV risk factors including blood pressure medication, lipid-lowering agents, and antiplatelet/anticoagulant therapy
Typical Escalation Schedule : Days 130: 3 mg daily (start dose) Days 3160: Escalate to 7 mg daily , if tolerated Day 61 onward: Possible increase to 14 mg daily , based on clinical response A missed dose should not be doubled